<DOC>
	<DOCNO>NCT01096589</DOCNO>
	<brief_summary>Objectives . The primary objective study ass volume reduction treatment lymphoedematous leg arm compression bandaging . Secondary objective : - Assessment safety - Quality life - Health economic parameter - Slippage - Subbandage pressure</brief_summary>
	<brief_title>Assessment 3M Oedema Reduction System Treatment Lymphoedema Compared Commercial Short-stretch Bandage</brief_title>
	<detailed_description />
	<mesh_term>Lymphedema</mesh_term>
	<mesh_term>Monensin</mesh_term>
	<criteria>Inclusion Criteria ( Arm ) : Mobile male female , age 18 year old Unilateral arm lymphoedema secondary origin Pitting arm lymphoedema diagnose stage II late stage II accord International Society Lymphology stag Patients require intense bandaging therapy ( approx . &gt; = 15 % increase arm volume opposite healthy arm ) Completion primary adjuvant cancer treatment ( surgery , chemotherapy , radiotherapy ) least 6 month prior randomisation Willing give write informed consent willing comply study protocol Inclusion Criteria ( Leg ) : Mobile male female , age 18 year old Unilateral bilateral leg lymphoedema primary secondary origin Pitting leg lymphoedema diagnose stage II late stage II accord International Society Lymphology stag Patients require intense bandaging therapy Completion primary adjuvant cancer treatment ( surgery , chemotherapy , radiotherapy ) least 6 month prior randomisation Willing give write informed consent willing comply study protocol Exclusion Criteria ( Arm ) : Known pregnancy Evidence active cancer , either local metastatic A period intense daily bandage within last month Decompensated heart failure clinically relevant kidney liver disease Known relevant arterial disease arm Deep vein thrombosis phlebitis last 3 month Paralysis arm Clinical infection arm ( e.g . erysipelas ) Wounds locate study arm require dress change week History allergic reaction study material Participation prospective clinical study potentially interfere study Participants , opinion clinical investigator , unsuitable enrolment study , reason specify exclusion criterion . Exclusion Criteria ( Leg ) : Known pregnancy Evidence active cancer , either local metastatic A period intense daily bandage within last month Decompensated heart failure clinically relevant kidney liver disease Deep vein thrombosis phlebitis last 3 month Known relevant arterial disease legs Paralysis legs Clinical infection leg ( e.g . erysipelas ) Circumferential Lymphorrhoea Wounds locate study leg require dress change week History allergic reaction study material Participation prospective clinical study potentially interfere study Participants , opinion clinical investigator , unsuitable enrolment study , reason specify exclusion criterion .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2012</verification_date>
	<keyword>lymphoedema</keyword>
	<keyword>lymphedema</keyword>
</DOC>